Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6N8UJ
|
|||
| Drug Name |
NAM-NK cells
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1 | [1] | |
| Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C82-C85; ICD-9: 200, 202] | Phase 1 | [1] | ||
| Company |
Gamida Cell
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03019666) Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.